Razelle Kurzrock joined the UC San Diego Moores Cancer Center in November 2012 as senior deputy center director for clinical science, with a broad mandate that includes growing and innovating the clinical trials program and heading the new Center for Personalized Cancer Therapy. She also serves as chief of the division of hematology oncology at the UC San Diego School of Medicine, and directs the clinical trials office, the experimental therapeutics team, and the UCSD Molecular Tumor Board. Dr. Kurzrock is widely recognized for her work in translational medicine. As a physician-scientist, she brings unique expertise and experience in clinical research, business operations, regulatory operations, financial and budget planning, and administrative oversight. While at the University of Texas M.D. Anderson Cancer Center, she created and led a department that enrolled about 1,200 patients on 128 therapies every year, and ranked as the world’s largest clinical trials department. She is a leader in the field of precision medicine, with expertise in cutting-edge molecular profiling technologies to match patients with novel targeted therapies, as well as biomarker-based advanced technologies to harness the immune system.